NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Search Results for Dana-Farber Cancer Institute


Filter Articles: Clinical News | Consumer News | Business News | All News | More Options

Results 1 - 20      Next >


Refine Search
Display Mode: Context | Summary
Aileron Therapeutics Collaborators Publish In Vivo Research in Nature Showing Stapled Peptides Achieve the First Direct Inhibition of the Notch1 Transcription Factor Oncogene
2009 NOV 23 ... called Stapled Peptides, announced that its collaborators, James E. Bradner, MD of the Dana-Farber Cancer Institute and the Broad Institute of Harvard and MIT, and Gregory L. Verdine, PhD, Professor of ...
Subject: Aileron Therapeutics
Price: $3.00
*
Findings from Brigham and Women's Hospital broaden understanding of non-hodgkin lymphoma therapy
2009 NOV 23 ... contact N.E. Martin, Brigham and Women's Hospital, Harvard Radiation Oncology Program, Dana-Farber Cancer Institute, Boston, MA 02115 USA.. Publisher contact information for the journal ...
Subject: Non-Hodgkin Lymphoma Therapy
Price: $3.00
*
Findings from Harvard University in paraproteinemia reported
2009 NOV 23 ... information, contact N.C. Munshi, Harvard University, School Medical, Dana Farber Cancer Institute, Jerome Lipper Multiple Myeloma Center, 44 Binney St., M1B28, Boston, MA ...
Subject: Paraproteinemia
Price: $3.00
*
Lankenau Institute Investigators Discover a Potential New Antibody Therapy To Treat Alzheimers Disease and Other Amyloid Illnesses
2009 NOV 23 ... Brigham and Women's Hospital, Massachusetts General Hospital and Dana Farber/Partners Cancer Care, all in Boston, MA. He was a postdoctoral fellow at the Whitehead Institute for ...
Subject: Alzheimer Disease
Price: $3.00
*
Recent findings in cytokines described by researchers from Harvard University
2009 NOV 23 ... information, contact J. Nolting, Harvard University, School Medical, Dana Farber Cancer Institute, Dept. of Cancer Immunology & AIDS, Boston, MA 02115, USA. The ...
Subject: Cytokines
Price: $3.00
*
Research from C.K. Hahn and colleagues provide new insights into proteomics
2009 NOV 23 ... proteomic, and genomic screening approaches to identify therapeutic strategies for cancer." Hahn and colleagues published their study in Cancer Cell (Proteomic and ... For additional information, contact K. Stegmaier, Dana Farber Cancer Institute, Dept. of Pediatrics Oncology, Boston, MA 02115, USA. Publisher contact ...
Subject: Proteomics
Price: $3.00
*
Research from Harvard University has provided new data on colon cancer
2009 NOV 23 ... "Vitamin D is associated with decreased risks of various cancers, including colon cancer. The vitamin D receptor (VDR) is a transcription factor, which plays an important role ... information, contact S. Ogino, Harvard University, School Medical, Dana Farber Cancer Institute, Center Molecular Oncology Pathology, Brigham & Women's Hospital, 44 Binney St., Room ...
Subject: Colon Cancer
Price: $3.00
*
Researchers 'notch' a victory toward new kind of cancer drug
2009 NOV 27 ... said senior author James Bradner, a Harvard chemical biologist and oncologist at the Dana-Farber Cancer Institute and an associate member of the Broad Institute of MIT and Harvard. "Our work brings us ...
Subject: Broad Institute of Mit and Harvard
Price: $3.00
*
Researchers at Brigham and Women's Hospital release new data on lymphoma prognosis
2009 NOV 16 ... 2009;20(11):1848-53). For additional information, contact D.J. Sher, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Dept. of Radiation Oncology, Boston, MA USA.. ...
Subject: Lymphoma Prognosis
Price: $3.00
*
Researchers from Harvard University report recent findings in cancer
2009 NOV 16 ... the need for further investigation of Wnt signaling components as potential targets for cancer therapy. Here, using expression profiling analysis as well as in vitro and in vivo ... contact D.R. Carrasco, Harvard University, School Medical, Dana Farber Cancer Institute, Dept. of Med Oncology, 44 Binney St., Dana 530C, Boston, MA 02115, USA. ...
Subject: Cancer
Price: $3.00
*
Researchers from Harvard University, Medical Department describe findings in breast cancer
2009 NOV 23 ... "Evidence suggests that exercise affects breast cancer risk and outcomes, but little is known about the mechanisms through which this effect ... Ligibel, Harvard University, School Medical, Dept. of Med Oncology, Dana Farber Cancer Institute, 44 Binney St., Boston, MA 02115, USA. The publisher's contact information ...
Subject: Breast Cancer
Price: $3.00
*
Scientists at Harvard University target virology
2009 NOV 16 ... information, contact J. Sodroski, Harvard University, School Medical, Dana Farber Cancer Institute, Dept. of Cancer Immunology & AIDS, Dept. of Pathology, Division AIDS, 44 ...
Subject: Virology
Price: $3.00
*
Studies from H.T. Ngo and co-authors have provided new information about waldenstrom macroglobulinemia
2009 NOV 16 ... According to recent research published in the journal Clinical Cancer Research, "Waldenstrom macroglobulinemia is a lymphoplasmacytic lymphoma characterized ... For additional information, contact I.M. Ghobrial, Dana Farber Cancer Institute, Kirsch Laboratory Waldenstrom, 44 Binney St., Mayer 548A, Boston, MA 02115, USA. ...
Subject: Waldenstrom Macroglobulinemia
Price: $3.00
*
Study results from H. Yamada et al provide new insights into prostate cancer
2009 NOV 23 ... "Two prostate cancer genome-wide scans in populations of European ancestry identified several genetic ... Yamada and colleagues published their study in the Journal of the National Cancer Institute (Replication of Prostate Cancer Risk Loci in a Japanese Case-Control Association Study. ...
Subject: Prostate Cancer
Price: $3.00
*
The American Society of Hematology Elects New Leadership
2009 NOV 16 ... Dr. Anderson, Kraft Family Professor of Medicine, Harvard Medical School, Dana-Farber Cancer Institute (DFCI), is Chief of the Division of Hematologic Neoplasia, Director of the Lipper ...
Subject: Cell Therapy
Price: $3.00
*
Tokai Pharmaceuticals Initiates ARMOR Clinical Development Program for TOK-001; First Ever Multi-Target Investigational Drug for Prostate Cancer
2009 NOV 23 ... of solid tumor oncology, and director, Lank Center for Genitourinary Oncology at the Dana-Farber Cancer Institute and professor of medicine, Harvard Medical School. "We now have a better understanding ...
Subject: Tokai Pharmaceuticals
Price: $3.00
*
WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board
2009 NOV 16 ... career has been focused on designing and commercializing novel molecular diagnostics for cancer detection and other applications, and on the development of computational biology ... academic appointments in the field of oncology at Children's Hospital Boston, The Broad Institute, Harvard Medical School and the Dana Farber Cancer Institute where he was responsible ...
Subject: Diagnostics
Price: $3.00
*
Washington Women in Public Relations Honors Sarah Temple with the 2009 'Washington PR Woman of the Year' Award
2009 NOV 17 ... campaign including its partnership with the Entertainment Industry Foundation/Stand Up 2 Cancer. The event also featured a keynote by Dana Bash, CNN's senior ... of experience includes spearheading the award-winning National Heart, Lung and Blood Institute's (NHLBI) "The Heart Truth" campaign, raising awareness about heart disease in women, ...
Subject: Washington Women in Public Relations
Price: $3.00
*
ZIOPHARM Presents Positive Palifosfamide Sarcoma Randomized Phase II Interim Data at Annual Meeting of the Connective Tissue Oncology Society
2009 NOV 23 ... MD, Director of the Center for Sarcoma and Bone Oncology and the Ludwig Center at the Dana-Farber Cancer Institute and Harvard Medical School, and a member of ZIOPHARM's Medical Advisory Board, whose ...
Subject: ZIOPHARM Oncology, Inc.
Price: $3.00
*

Results 1 - 20      Next >




-----------------------
PR Login